Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: E9AX56
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 73 | 77 | PF00656 | 0.563 |
CLV_NRD_NRD_1 | 292 | 294 | PF00675 | 0.636 |
CLV_NRD_NRD_1 | 297 | 299 | PF00675 | 0.633 |
CLV_NRD_NRD_1 | 65 | 67 | PF00675 | 0.429 |
CLV_PCSK_KEX2_1 | 290 | 292 | PF00082 | 0.646 |
CLV_PCSK_KEX2_1 | 296 | 298 | PF00082 | 0.628 |
CLV_PCSK_PC1ET2_1 | 290 | 292 | PF00082 | 0.718 |
CLV_PCSK_PC7_1 | 292 | 298 | PF00082 | 0.628 |
CLV_PCSK_SKI1_1 | 203 | 207 | PF00082 | 0.657 |
CLV_PCSK_SKI1_1 | 66 | 70 | PF00082 | 0.442 |
DOC_CYCLIN_yCln2_LP_2 | 177 | 183 | PF00134 | 0.363 |
DOC_MAPK_DCC_7 | 277 | 286 | PF00069 | 0.705 |
DOC_MAPK_gen_1 | 277 | 286 | PF00069 | 0.705 |
DOC_MAPK_MEF2A_6 | 277 | 286 | PF00069 | 0.705 |
DOC_MAPK_MEF2A_6 | 92 | 101 | PF00069 | 0.396 |
DOC_PP2B_LxvP_1 | 101 | 104 | PF13499 | 0.432 |
DOC_PP2B_LxvP_1 | 284 | 287 | PF13499 | 0.710 |
DOC_USP7_MATH_1 | 152 | 156 | PF00917 | 0.562 |
DOC_USP7_MATH_1 | 168 | 172 | PF00917 | 0.642 |
DOC_USP7_MATH_1 | 201 | 205 | PF00917 | 0.628 |
DOC_USP7_MATH_1 | 247 | 251 | PF00917 | 0.779 |
DOC_USP7_MATH_1 | 3 | 7 | PF00917 | 0.379 |
DOC_WW_Pin1_4 | 13 | 18 | PF00397 | 0.643 |
DOC_WW_Pin1_4 | 176 | 181 | PF00397 | 0.570 |
DOC_WW_Pin1_4 | 224 | 229 | PF00397 | 0.753 |
DOC_WW_Pin1_4 | 266 | 271 | PF00397 | 0.734 |
LIG_14-3-3_CanoR_1 | 122 | 127 | PF00244 | 0.625 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.582 |
LIG_BIR_III_2 | 76 | 80 | PF00653 | 0.264 |
LIG_Clathr_ClatBox_1 | 126 | 130 | PF01394 | 0.539 |
LIG_eIF4E_1 | 85 | 91 | PF01652 | 0.360 |
LIG_FHA_1 | 24 | 30 | PF00498 | 0.551 |
LIG_LIR_Apic_2 | 233 | 239 | PF02991 | 0.719 |
LIG_LIR_Gen_1 | 135 | 144 | PF02991 | 0.489 |
LIG_LIR_Gen_1 | 188 | 196 | PF02991 | 0.469 |
LIG_LIR_Gen_1 | 60 | 70 | PF02991 | 0.413 |
LIG_LIR_Nem_3 | 135 | 139 | PF02991 | 0.395 |
LIG_LIR_Nem_3 | 188 | 193 | PF02991 | 0.465 |
LIG_LIR_Nem_3 | 60 | 65 | PF02991 | 0.382 |
LIG_LIR_Nem_3 | 82 | 87 | PF02991 | 0.426 |
LIG_NRBOX | 160 | 166 | PF00104 | 0.606 |
LIG_PALB2_WD40_1 | 124 | 132 | PF16756 | 0.536 |
LIG_PTAP_UEV_1 | 227 | 232 | PF05743 | 0.591 |
LIG_SH2_CRK | 145 | 149 | PF00017 | 0.523 |
LIG_SH2_CRK | 236 | 240 | PF00017 | 0.759 |
LIG_SH2_CRK | 31 | 35 | PF00017 | 0.533 |
LIG_SH2_NCK_1 | 236 | 240 | PF00017 | 0.585 |
LIG_SH2_STAP1 | 25 | 29 | PF00017 | 0.579 |
LIG_SH2_STAT3 | 109 | 112 | PF00017 | 0.426 |
LIG_SH2_STAT5 | 109 | 112 | PF00017 | 0.405 |
LIG_SH2_STAT5 | 25 | 28 | PF00017 | 0.575 |
LIG_SH2_STAT5 | 268 | 271 | PF00017 | 0.647 |
LIG_SH2_STAT5 | 85 | 88 | PF00017 | 0.353 |
LIG_SH3_3 | 14 | 20 | PF00018 | 0.671 |
LIG_SH3_3 | 225 | 231 | PF00018 | 0.792 |
LIG_SH3_3 | 94 | 100 | PF00018 | 0.391 |
LIG_TYR_ITIM | 29 | 34 | PF00017 | 0.527 |
MOD_CDK_SPK_2 | 13 | 18 | PF00069 | 0.704 |
MOD_CK1_1 | 224 | 230 | PF00069 | 0.764 |
MOD_CK1_1 | 256 | 262 | PF00069 | 0.719 |
MOD_CK1_1 | 58 | 64 | PF00069 | 0.504 |
MOD_CK2_1 | 154 | 160 | PF00069 | 0.481 |
MOD_Cter_Amidation | 294 | 297 | PF01082 | 0.758 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.463 |
MOD_GlcNHglycan | 145 | 148 | PF01048 | 0.466 |
MOD_GlcNHglycan | 156 | 159 | PF01048 | 0.431 |
MOD_GlcNHglycan | 21 | 24 | PF01048 | 0.372 |
MOD_GlcNHglycan | 228 | 231 | PF01048 | 0.696 |
MOD_GlcNHglycan | 255 | 258 | PF01048 | 0.720 |
MOD_GlcNHglycan | 5 | 8 | PF01048 | 0.617 |
MOD_GlcNHglycan | 57 | 60 | PF01048 | 0.451 |
MOD_GSK3_1 | 19 | 26 | PF00069 | 0.560 |
MOD_GSK3_1 | 222 | 229 | PF00069 | 0.741 |
MOD_GSK3_1 | 243 | 250 | PF00069 | 0.675 |
MOD_N-GLC_1 | 222 | 227 | PF02516 | 0.682 |
MOD_N-GLC_1 | 79 | 84 | PF02516 | 0.451 |
MOD_NEK2_1 | 107 | 112 | PF00069 | 0.512 |
MOD_NEK2_2 | 201 | 206 | PF00069 | 0.685 |
MOD_PIKK_1 | 256 | 262 | PF00454 | 0.780 |
MOD_Plk_1 | 107 | 113 | PF00069 | 0.515 |
MOD_Plk_1 | 168 | 174 | PF00069 | 0.599 |
MOD_Plk_1 | 79 | 85 | PF00069 | 0.487 |
MOD_Plk_4 | 122 | 128 | PF00069 | 0.550 |
MOD_Plk_4 | 201 | 207 | PF00069 | 0.651 |
MOD_ProDKin_1 | 13 | 19 | PF00069 | 0.637 |
MOD_ProDKin_1 | 176 | 182 | PF00069 | 0.564 |
MOD_ProDKin_1 | 224 | 230 | PF00069 | 0.752 |
MOD_ProDKin_1 | 266 | 272 | PF00069 | 0.734 |
TRG_DiLeu_BaEn_1 | 160 | 165 | PF01217 | 0.606 |
TRG_DiLeu_BaLyEn_6 | 102 | 107 | PF01217 | 0.449 |
TRG_ENDOCYTIC_2 | 145 | 148 | PF00928 | 0.512 |
TRG_ENDOCYTIC_2 | 31 | 34 | PF00928 | 0.525 |
TRG_ER_diArg_1 | 291 | 293 | PF00400 | 0.636 |
TRG_ER_diArg_1 | 296 | 298 | PF00400 | 0.629 |
TRG_NES_CRM1_1 | 124 | 137 | PF08389 | 0.549 |
TRG_Pf-PMV_PEXEL_1 | 67 | 71 | PF00026 | 0.527 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I0R9 | Leptomonas seymouri | 67% | 99% |
A0A0S4IT31 | Bodo saltans | 27% | 100% |
A0A1X0NWE2 | Trypanosomatidae | 38% | 100% |
A0A3R7MR43 | Trypanosoma rangeli | 39% | 100% |
A0A3S7WYL9 | Leishmania donovani | 93% | 99% |
A4HDS1 | Leishmania braziliensis | 85% | 100% |
A4I119 | Leishmania infantum | 92% | 99% |
C9ZW91 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 39% | 100% |
Q4QAC0 | Leishmania major | 92% | 100% |
V5AV25 | Trypanosoma cruzi | 39% | 99% |